Literature DB >> 1427616

Serum procalcitonin as an index of inhalation injury in burns.

E S Nylen1, W O'Neill, M H Jordan, R H Snider, C F Moore, M Lewis, O L Silva, K L Becker.   

Abstract

The molecular heterogeneity of serum immunoreactive calcitonin (iCT) was analyzed from a prospective study of 41 burn patients. Using different region-specific anticalcitonin antisera, the ratio of mid-region-recognizing to carboxyl terminal-region-recognizing iCT was found to increase acutely in those who subsequently died. The highest ratios occurred in those who died early of respiratory complications. Sephadex chromatography and reversed-phase HPLC demonstrated that the serum iCT circulated predominantly in the large molecular mass prohormone form (16 kDa). In comparison, iCT of normal human lung and of normal thyroid was shown to consist primarily of smaller monomeric mass forms. Furthermore, in 12 normal volunteers who were evaluated with a calcium-pentagastrin infusion, the ratio of iCT levels did not differ from the baseline ratio despite a 50% increase in serum iCT. These results suggest that in burns, the inhalational injury-associated hypercalcitonemia is characterized by a preferential release of procalcitonin; a form of constitutive secretion. The measurement of serum procalcitonin levels would appear to be a useful prognostic indicator of the severity of inhalational injury occurring in burn patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1427616     DOI: 10.1055/s-2007-1003354

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  15 in total

Review 1.  Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.

Authors:  Kenneth L Becker; Richard Snider; Eric S Nylen
Journal:  Br J Pharmacol       Date:  2009-11-27       Impact factor: 8.739

2.  The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis.

Authors:  B Rau; G Steinbach; F Gansauge; J M Mayer; A Grünert; H G Beger
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

Review 3.  Biomarkers in the diagnosis of aspiration syndromes.

Authors:  Philippe Abou Jaoude; Paul R Knight; Patricia Ohtake; Ali A El-Solh
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

4.  Procalcitonin and pneumonia: is it a useful marker?

Authors:  Mirjam Christ-Crain; Beat Müller
Journal:  Curr Infect Dis Rep       Date:  2007-05       Impact factor: 3.725

5.  The importance of determining procalcitonin and C reactive protein in different stages of sepsis.

Authors:  Zana Baruti Gafurri; Hidajet Pacarizi; Bukurije Zhubi; Luljeta Begolli; Valdete Topciu
Journal:  Bosn J Basic Med Sci       Date:  2010-02       Impact factor: 3.363

6.  The relationship between procalcitonin and thyroid autoantibodies in patients with autoimmune thyroiditis.

Authors:  Ali Oncul; Ihsan Ates; Mehmet Fettah Arikan; Nisbet Yilmaz; Canan Topcuoglu; Fatma Meric Yilmaz; Mustafa Altay
Journal:  J Clin Lab Anal       Date:  2017-02-07       Impact factor: 2.352

7.  Serum procalcitonin as a predictor of infectious complications after pancreaticoduodenectomy: review of the literature and our experience.

Authors:  Hiroya Iida; Hiromitsu Maehira; Haruki Mori; Masaji Tani
Journal:  Surg Today       Date:  2019-04-16       Impact factor: 2.549

8.  Procalcitonin (PCT) in patients with abdominal sepsis.

Authors:  H B Reith; U Mittelkötter; R Wagner; A Thiede
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

9.  Neonatal Procalcitonin Intervention Study (NeoPInS): Effect of Procalcitonin-guided decision making on duration of antibiotic therapy in suspected neonatal early-onset sepsis: A multi-centre randomized superiority and non-inferiority Intervention Study.

Authors:  Martin Stocker; Wim C J Hop; Annemarie M C van Rossum
Journal:  BMC Pediatr       Date:  2010-12-08       Impact factor: 2.125

10.  Cytokine levels in abdominal exudate predict prolonged postoperative ileus following surgery for colorectal carcinoma.

Authors:  Pengcheng Zhu; Honghua Jiang; Jihong Fu; Wei Chen; Zhongchuan Wang; Long Cui
Journal:  Oncol Lett       Date:  2013-07-15       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.